redorbit.com
May 16, 2008
Posted on: Friday, 16 May 2008, 12:00 CDT NATICK, Mass., May 16 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval of its ACUITY(R) Spiral left ventricular lead for use with cardiac resynchronization therapy defibrillators...
[read full story]